This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Korea to invest $836 million in global R&D in 2024; focus on AI, biotech, semiconductors, quantum computing

( November 20, 2023, 07:33 GMT | Official Statement) -- MLex Summary: The South Korean government has outlined a strategic plan to significantly boost its global R&D investments in 2024, committing 1.08 trillion won (about $836.1 million). According to a statement from the Ministry of Science and ICT, South Korea's global R&D spending, at just 1.6 percent of its government R&D budget, is significantly lower than countries such as Italy, the UK and Germany. The investment strategy prioritizes key technological sectors including biotechnology, AI, quantum computing, and semiconductors. Additionally, the plan aims to enhance the global presence and collaborative efforts of young, talented researchers and establish data-driven cooperation strategies across various countries and technological fields.The statement, in Korean, is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login